Growing Prevalence of Opioid Use Disorder Drives the Global Opioid Use Disorder Market

Ben Wood

Growing Prevalence of Opioid Use Disorder Drives the Global Opioid Use Disorder Market

The global opioid use disorder market is estimated to be valued at US$2,739.2 million in 2021 and is expected to exhibit a CAGR of 8.7% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Opioid use disorder refers to a chronic condition characterized by the compulsive use of opioids, despite harmful consequences. The market for opioid use disorder treatments is witnessing significant growth due to the rising prevalence of opioid addiction worldwide. Opioid addiction has become a major public health concern, and there is a growing need for effective treatment options. The market offers various products and therapies, including medication-assisted treatments, counseling, and behavioral therapies, to help individuals with opioid use disorder recover and lead healthier lives. These treatments provide advantages such as reducing cravings, preventing relapse, and improving overall well-being.

Market Key Trends:

Amidst the opioid epidemic, one key trend observed in the opioid use disorder market is the increasing adoption of medication-assisted treatment (MAT). MAT involves the use of FDA-approved medications, along with counseling and behavioral therapies, to treat opioid addiction. This approach has gained prominence due to its effectiveness in reducing withdrawal symptoms, preventing relapse, and improving treatment outcomes. Buprenorphine, methadone, and naltrexone are the commonly used medications under MAT. The rising awareness about the benefits of MAT, along with supportive government initiatives and reimbursement policies, is driving its adoption among healthcare providers and patients alike. As a result, the demand for medications used in MAT is expected to witness substantial growth in the coming years.

Overall, the global opioid use disorder market is witnessing significant growth due to the increasing prevalence of opioid

Segment Analysis:

The opioid use disorder market can be segmented by product type and end user. Based on product type, the market can be divided into opioid agonists, opioid antagonists, and combination drugs. Opioid agonists dominate the market segment due to their higher efficacy in managing opioid dependence and reducing withdrawal symptoms. Opioid agonists such as methadone and buprenorphine are widely used in the treatment of opioid use disorder. These drugs work by activating the opioid receptors in the brain, thereby reducing cravings and preventing withdrawal symptoms. The dominance of the opioid agonists segment can also be attributed to their long-acting nature, which allows for once-daily dosing and improves patient adherence to treatment.

Key Takeaways:

The global opioid use disorder market is expected to witness high growth, exhibiting a CAGR of 8.7% over the forecast period (2023-2030). This growth can be attributed to several factors, including the increasing prevalence of opioid use disorder worldwide, rising awareness about the benefits of medication-assisted treatment, and the development of novel and effective drugs for opioid dependence.

In terms of regional analysis, North America is expected to be the fastest-growing and dominating region in the opioid use disorder market. This can be attributed to the high prevalence of opioid use disorder in the region, favorable government initiatives to tackle the opioid crisis, and the presence of key market players. The United States, in particular, accounts for a significant share of the market in North America.

Key players operating in the opioid use disorder market include Indivior PLC, Alkermes, Orexo AB, Titan Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, BioDelivery Sciences International Inc., Viatris Inc., Pfizer, Inc., Hikma Pharmaceuticals PLC, and Camurus. These key players are actively involved in research and development activities to develop innovative treatment options for opioid use disorder and expand their market presence. The competitive landscape of the market is characterized by partnerships, collaborations, and product launches, aimed at gaining a competitive advantage in the market.

https://www.newswirestats.com/opioid-use-disorder-market-is-estimated-to-witness-high-growth-owing/

Ben Wood

Global Opioid Use Disorder Market Report 2021-2028 by Key Players Titan Pharmaceuticals, Hikma Pharmaceuticals, Teva Pharmaceuticals, MediciNova, Orexo, Camurus, Omeros

Sheryl Dias 2022-04-08

The global opioid use disorder market size is projected to expand at a significant CAGR during the forecast period, 2021–2028. About Growth Market Reports:GROWTH MARKET REPORTS provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Industry Intelligence Solutions”. Our key analysis segments, though not restricted to the same, include market entry strategies, market size estimations, market trend analysis, market opportunity analysis, market threat analysis, market growth/fall forecasting, primary interviews, secondary research & consumer surveys. Contact:Growth Market Reports Phone: +1 909 414 1393 Email: sales@growthmarketreports. com Follow Us: LinkedIn | Twitter

Opioid Use Disorder Market Competitive Strategies, Advertising Trends, Market Analysis by 2028

Data Bridge Market Research 2022-03-17

The Opioid Use Disorder Market is expected to witness market growth at a rate of 8. The Opioid Use Disorder Market Scope and SizeA credible Opioid Use Disorder Market research report is generated by using integrated approaches and latest technology for the best results. Global Opioid Use Disorder Market report is sure to help enhance sales and improve return on investment (ROI). , Alkermes, Novartis AG, Pear Therapeutics, Inc among other domestic and global playersMAJOR TOC OF THE REPORTChapter One: Opioid Use Disorder Market OverviewChapter Two: Manufacturers ProfilesChapter Three: Opioid Use Disorder Market Competition, by PlayersChapter Four: Opioid Use Disorder Market Size by RegionsChapter Five: Opioid Use Disorder Market Revenue by CountriesChapter Six: Opioid Use Disorder Market Revenue by TypeChapter Seven: Opioid Use Disorder Market Revenue by ApplicationChapter Eight: Opioid Use Disorder Market Revenue by IndustriesChapter Nine: Opioid Use Disorder Market Revenue by Deployment ModelChapter Ten: Opioid Use Disorder Market Revenue by End UserGet TOC Details: https://www. com

Opioid Use Disorder Market Is Estimated To Witness High Growth Owing To Increasing Prevalence of Opioid Addiction

Anjali CMI 2023-09-29

The global Opioid Use Disorder Market is estimated to be valued at US$ 2,739. In conclusion, the Opioid Use Disorder Market is projected to witness high growth in the coming years, driven by the increasing prevalence of opioid addiction and the growing adoption of medication-assisted treatments. These trends highlight the need for effective interventions and support systems to address the challenges associated with opioid use disorder. Economic: The economic factors affecting the Opioid Use Disorder market include healthcare expenditure, insurance coverage, and affordability of opioid addiction treatments. In terms of regional analysis, North America is the fastest-growing and dominating region in the Opioid Use Disorder market.

Opioid Use Disorder Market Growth and Opportunities Analysis Report 2030

amols shinde 2024-03-18

The signs of opioid use disorder include an intense desire to take opioids, a rise in opioid tolerance, and withdrawal symptoms after stopping. The market for opioid use disorder is expected to rise as buprenorphine patches gain popularity as an efficient treatment for opioid use disorder. Buprenorphine patches are thought to be a cutting-edge approach to treating opioid use disorder. license=singleAbout We Market Research: WE MARKET RESEARCH is an established market analytics and research firm with a domain experience sprawling across different industries. Robbin Joseph Corporate Sales, USA We Market Research USA: +1-724-618-3925 Websites: https://wemarketresearch.

E-Prescribing Is Fastest Growing Segment Fueling The Growth Of Opioid Use Disorder Market

Leena Shedmake 2023-12-14

The global Opioid Use Disorder Market is estimated to be valued at US$ 3236. Segment AnalysisThe opioid use disorder market is segmented by type, application, and distribution channel. The addiction treatment segment holds the largest share in the opioid use disorder market owing to the increasing prevalence of opioid addiction globally. Key Takeaways The Global Opioid Use Disorder Market Size is expected to witness high growth, exhibiting a CAGR of 8. Regional analysis: North America holds the largest share in the opioid use disorder market owing to the high prevalence of opioid addiction in countries like the U.

Understanding the Complex Challenges of Opioid Use Disorder

Sneha 2024-03-20

The Rise of the Opioid EpidemicOver prescription of opioid painkillers in the late 1990s helped spark today’s ongoing Opioid Use Disorder overdose epidemic. Understanding the Biology of Opioid AddictionRepeated opioid use hijacks the brain’s reward system by flooding the nucleus accumbens with dopamine, making activities like eating, sleeping, and sex less appealing. This surge of the “feel-good” neurotransmitter conditions people to associate drug use with pleasure and increasingly prioritize it over other activities. 5 million Americans have an opioid use disorder but only 10% receive treatment. Get more insights on Opioid Use Disorder

WHO TO FOLLOW

MORE FROM AUTHOR

Software testing and QA services market Is Estimated To Witness High Growth

Ben Wood 2023-11-08

Primary Care Physicians Market Is Estimated To Witness High Growth Owing To Increasing Healthcare Expenditure And Aging Population

Ben Wood 2023-11-08

Market Is Estimated To Witness High Growth Owing To Increased Focus On Quality Assurance and Regulatory Approval

Ben Wood 2023-11-07

Market Is Estimated To Witness High Growth Owing To Increased Administration Efficacy And Patient Compliance

Ben Wood 2023-11-07

Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.

Press enter to search

Opioid Use Disorder Treatment Market Report 2023: R&D Consistency Drives Sector Growth

Ganesh Shinde 2023-02-15

The global Opioid Use Disorder Treatment Market size is expected to attain an impressive valuation of US$ 3. This expands their consumer base, which directly contributes to the market expansion of Opioid use disorder treatment. Competitive LandscapeThe Opioid use disorder treatment Market is competitive and consists of several major players. This is expected to propel Opioid use disorder treatment market. com/reports/opioid-use-disorder-treatment-marketKey Segments Profiled in the Opioid Use Disorder Treatment Market SurveyBy Drug Type:RomiplostimOmidubicelNalmefeneBuprenorfineMethadoneNaltrexoneBy Route of Administration:OralParenteralBy Distribution Channel:Hospital PharmaciesRetail PharmaciesOnline Pharmacies

Global Opioids Use Disorder Market 2022 - Top Key Players Analysis Report Till 2028

Anoki Sharma 2023-02-01

COVID-19 Impact Analysis on Opioids Use Disorder Market report published by Value Market Research provides a detailed market analysis comprising market size, share, value, growth and trends for the period 2022-2028. The major players in the opioids use disorder market include Alkermes Inc. Get more information on "Global Opioids Use Disorder Market Research Report" by requesting FREE Sample Copy at https://www. Browse Global Opioids Use Disorder Market Research Report with detailed TOC at https://www. By Drug Type· Agonist (Type (Methadone, Buprenorphine))· AntagonistBy Age Group· 19 To 39· 40 To 59· Age 60 And OverBy Route Of Administration· Oral· Intravenous· SublingualBy Distribution Channal· Hospital Pharmacy· Retail PharmacyRegional AnalysisThis section covers the regional outlook, which accentuates current and future demand for the Opioids Use Disorder market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

Major Depressive Disorder (MDD) Treatment Includes Genetic Testing, Biomarkers, And Targeted Therapies

Pooja salve 2023-05-17

In addition to genetic testing and biomarkers, personalized medicine in Major Depressive Disorder (MDD) Treatment also involves the use of targeted therapies. Traditional antidepressant medications, such as selective serotonin reuptake inhibitors (SSRIs), work by increasing the availability of neurotransmitters in the brain. For example, the drug ketamine, originally used as an anesthetic, has demonstrated rapid and robust antidepressant effects in treatment-resistant MDD. Personalized medicine in the Major Depressive Disorder (MDD) Treatment encompasses various approaches, including genetic testing, biomarkers, and targeted therapies. Incorporating stress management techniques such as mindfulness meditation, deep breathing exercises, and relaxation techniques can help individuals with MDD better cope with stressors.

Global Non-Opioid Pain Patch Market 2023: Future Dynamics And Innovative Strategies By 2032

Sushmitha 2023-11-23

The Non-Opioid Pain Patch Global Market Report 2023, provides comprehensive information on the non-opioid pain patch market across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. Learn More On The Non-Opioid Pain Patch Market’s Growth:https://www. The non-opioid pain patch market is expected to reach $4. The non-opioid pain patch market is segmented:1) By Patch: Lidocaine Patches, Diclofenac Patches, Capsaicin Patches, Ketoprofen Patches, Other Patches2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels3) By Indication: Musculoskeletal Pain, Neuropathic PainNorth America was the largest region in the non-opioid pain patch market in 2022. The table of contents in TBRC’s non-opioid pain patch market report includes:1.

Opioid Use Disorder - A Growing Epidemic Threatening Public Health

Dhanesha Patil 2024-02-05

This article explores the causes, consequences and potential solutions to the ongoing opioid crisis. Defining Opioid Use Disorder Opioid use disorder refers to problematic patterns of using opioids that cause significant impairment or distress. According to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), opioid use disorder is diagnosed based on experiencing at least two of eleven criteria within the past year including taking opioids in larger amounts or for longer than intended, cravings to use opioids, reduced participation in activities due to opioid use and continued use despite physical or psychological problems from opioids. Lax regulations and failure of medical groups and government to curb reckless prescribing fueled the increase in opioid addiction and overdoses. Public Health Emergency Response In 2017, the federal government declared the opioid crisis a national public health emergency, directing increased funding towards prevention and treatment efforts.

Opioids Use Disorder Market : Why it matters and 5 key areas for action

Snehitha Reddy 2022-12-02

According to the report published by Allied Market Research, the global opioids use disorder market was estimated at $2. Moreover, the postponement or cancellation of doctor appointments affected the global opioids use disorder market severely. reqfor=covidThe global opioids use disorder market is analyzed across drug type, age group, route of administration, distribution channel, and region. com/purchase-enquiry/12668The key market players analyzed in the global opioids use disorder market report include AstraZeneca Plc. comAbout us:Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon.

Opioid Analgesics Market Technology, Key Manufacturers Report

Chetna Noor 2023-06-30

The major players in the opioid analgesics market include Pfizer Inc, Abbott Laboratories, Janssen Pharmaceuticals, Inc. Get more information on "Global Opioid Analgesics Market Research Report" by requesting FREE Sample Copy at https://www. Nevertheless, the increasing prevalence of opioid misuse is projected to hamper the expansion of the opioid analgesics industry. Browse Global Opioid Analgesics Market Research Report with detailed TOC at https://www. Purchase Complete Global Opioid Analgesics Market Research Report at https://www.

Non-Opioid Pain Treatment Market Growth: Research Report Overview

Delvens 2024-01-02

Get a Sample Copy of the Non-Opioid Pain Treatment Market Research Report: https://www. Gain authentic and granular data access for Non-opioid Pain Treatment Market so as to understand the trends and the factors involved behind changing market situations. Direct Purchase of Non-Opioid Pain Treatment Market Report Research Report: https://www. com/checkout/non-opiod-pain-treatment-marketFrequently Asked QuestionsWhat are the years considered to study Non-opioid Pain Treatment Market intelligence report? Which region holds the largest market share in Non-opioid Pain Treatment Market? Which region holds the largest market share in Non-opioid Pain Treatment Market?

Opioid Use Disorder Market Covid-19 Analysis Expected to Witness a Sustainable Growth over 2028

dev smith 2021-09-13

The Opioid Use Disorder Market analysis report is accomplished with transparent research studies and is generated by a team work of experts in their own domain.

The study conducted for Opioid Use Disorder industry also analyzes the market status, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, and distributors with the help of SWOT analysis and Porter's Five Forces Analysis.Businesses can successfully utilize the data, statistics, research, and insights about the Opioid Use Disorder industry included in this Opioid Use Disorder business report to make decisions about business strategies and to achieve maximum return on investment (ROI).

This market report helps to provide such market insights by considering all the aspects of current and future market.

Opioid Use Disorder market research report helps the clients get familiar with the various drivers and restraints influencing the Opioid Use Disorder industry during the forecast period.Get Download Free Sample Copy @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-opioid-use-disorder-marketAll this helps to enhance the company’s growth, by subsidizing the risk and improving their performance.

International Opioid Use Disorder report also studies company profiles with respect to company snapshot, geographical presence, product portfolio, and recent developments.Winning Opioid Use Disorder Market report is built by chewing over several fragments of the present and upcoming market scenario because an utter way to forecast what future holds is to comprehend the trend today.Significant Major Market Competitors/Players of this Global Opioid Use Disorder Market –Indivior PLC, Teva Pharmaceutical Industries Ltd., Omeros Corporation, Camurus, Hikma Pharmaceuticals PLC, Titan Pharmaceuticals, Inc., BioDelivery Sciences International, Inc., Alkermes, Novartis AG, Pear Therapeutics, Inc., Amygdala Neurosciences, Inc., Orexo AB (publ.

), Braeburn Inc., iX Biopharma Ltd., Relmada Therapeutics, Inc. and Mundipharma International, among other domestic and global playersSegmentation Of the Global Opioid Use Disorder Market –Opioid Use Disorder Market by Drug -BuprenorphineMethadoneNaltrexoneOpioid Use Disorder Market by Distribution Channel –Hospital PharmaciesRetail PharmaciesOnline PharmaciesOpioid Use Disorder Market by End User –HospitalsHomecareSpecialty ClinicsOthersActionable market insights are always very important if seeking to create sustainable and profitable business strategies.

Opioid Analgesics Market Size, Share, Regional Overview and Global Forecast to 2028

Betty Johns 2022-01-24

COVID-19 Impact Analysis on Opioid Analgesics Market report published by Value Market Research provides a detailed market analysis comprising market size, share, value, growth and trends for the period 2022-2028. The major players in the opioid analgesics market include Pfizer Inc, Abbott Laboratories, Janssen Pharmaceuticals, Inc. Get more information on "Global Opioid Analgesics Market Research Report" by requesting FREE Sample Copy at https://www. Browse Global Opioid Analgesics Market Research Report with detailed TOC at https://www. By Drug Class· Morphine· Codeine· Fentanyl· Meperidine· Methadone· Tramadol· Oxycodone· Dextromethorphan· Buprenorphine· OthersBy Indication· Surgical Pain· Cancer Pain· Neuropathic Pain· OtherBy Route Of Administration· Oral· Parenteral· Transdermal· OtherBy End User· Hospitals· Retail Pharmacies· Drug Stores· Online PharmaciesRegional AnalysisThis section covers the regional outlook, which accentuates current and future demand for the Opioid Analgesics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

Opioid Withdrawal Treatment Market Growth, Revenue, Key Factors, Major Companies, Forecast To 2027

Jason Miller 2022-02-09

The global opioid withdrawal treatment growth market held a market value of USD 1. In some cases, usage of opioids causes addiction, and Opioid withdrawal syndrome is a life-threatening condition resulting from opioid dependence. Hence this opioid dependence requires treatment, which is known as opioids withdrawal treatment. Key PlayersSome of the prominent players in the global opioid withdrawal treatment market are Merck & Co. Europe accounts for the second-largest market and holds a healthy share in the global opioid withdrawal treatment market due to major driving factors like availability of advanced treatment facilities, increasing healthcare expenditure, and flourishing pharmaceutical industry due to the presence of major market players.

Opioid Use Disorder Market Share, Demand, Growth, Top Companies and Opportunities by 2028

Ispita Smith 2021-11-02

This Opioid Use Disorder Market report comprises of comprehensive and thorough insights which are based on business intelligence.

In addition, businesses can recognize the extent of the marketing problems, causes for failure of particular product (if any) already in the market, and prospective market for a new product to be launched.

Markets at local, regional and global level are considered in this Opioid Use Disorder report.This market report also puts light on historic data, present market trends, future products environment, marketing strategies, technological innovation, upcoming technologies, emerging opportunities, and the technical progress in the related industry.Get Download Free Sample Copy @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-opioid-use-disorder-marketThis Opioid Use Disorder market research report provides a profound overview of product specification, technology, product type and production analysis considering major factors such as Revenue, Cost, Gross and Gross Margin.

This report gives an absolute background analysis of the Opioid Use Disorder industry which includes an assessment of the parental market.Market research analysis and insights covered in this report are very considerate for the businesses to make better decisions, to develop better strategies about production, marketing, sales and promotion of a particular product and thereby extending their reach towards the success.Segmentation of the Global Opioid Use Disorder Market –Opioid Use Disorder Market by Drug –BuprenorphineMethadoneNaltrexoneOpioid Use Disorder Market by Application –Moderate Pain TreatmentSevere Pain TreatmentOpioid Use Disorder Market by End User –HospitalsHomecareSpecialty ClinicsOthersTop Key Players of this Global Opioid Use Disorder Market –Indivior PLC, Teva Pharmaceutical Industries Ltd., Omeros Corporation, Camurus, Hikma Pharmaceuticals PLC, Titan Pharmaceuticals, Inc., BioDelivery Sciences International, Inc., Alkermes, Novartis AG, Pear Therapeutics, Inc., Amygdala Neurosciences, Inc., Orexo AB (publ.

), Braeburn Inc., iX Biopharma Ltd., Relmada Therapeutics, Inc. and Mundipharma International, among other domestic and global players .Get Detailed Toc and Charts & Tables @ https://www.databridgemarketresearch.com/toc/?dbmr=global-opioid-use-disorder-marketMajor goals of Opioid Use Disorder Market report can be listed as;Identify the reasons for failure of a product already in the market.Discover the better methods of distributing the products to consumers.Know the types of consumers and their buying motives.Recognize opinions and get suggestion for improvement of a product by consumers.Measure the strength and weakness of the competitors.Know the dimensions of the marketing problems.Estimate the market share of a firm.Calculate the probable sales volume of a firm.Country (U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, Italy, U.K., Belgium, Spain, Russia, Turkey, Netherlands, Switzerland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, U.A.E, Saudi Arabia, Egypt, South Africa, Israel, Rest of Middle East and Africa)Want Full Report?

Enquire Here - https://www.databridgemarketresearch.com/reports/global-opioid-use-disorder-marketGlobal Opioid Use Disorder Market research report offers:Market definition of the global Opioid Use Disorder market along with the analysis of different influencing factors like drivers, restraints, and opportunities.A comprehensive list of key market players operating in the global Opioid Use Disorder market.Statistical analysis of some significant economics factsWhich are the key manufacturers in the Opioid Use Disorder market?About Us:Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches.

Opioid Analgesics Market Size, Share, Regional Overview and Global Forecast to 2027

DarshikaSingh 2021-12-13

Opioid Habit and Dependence Market Revenue Analysis, Company Revenue Share, Global Forecast Till 2030

jhon tanison 2022-11-17

It is an investigative study covering analysis of market drivers, restraints, challenges, threats, and growth prospects in the global Opioid Habit and Dependence market. The global Opioid Habit and Dependence market report is a methodical research of the Opioid Habit and Dependence market done by extensive primary and secondary research. The fundamental purpose of the Opioid Habit and Dependence market report is to offer an accurate and strategic analysis of the Opioid Habit and Dependence business sphere. com/report-pricing/5428 Regional analysis covers in-depth analysis of analysis of the revenue, market share, and growth rate of the global Opioid Habit and Dependence market in each region for the forecast period of 2021-2028. com